Skip to main content

Table 1 Demographics of the young and middle-aged female patients with schizophrenia

From: Effectiveness and safety of blonanserin in young and middle-aged female patients with schizophrenia: data from a post-marketing surveillance

Variates

Category

Blonanserin group (n = 392)

Age

Mean ± SD

28.0 ± 6.2

Height (cm)

Mean ± SD

163.1 ± 3.1

Weight (kg)

Mean ± SD

61.5 ± 12.6

Duration of illness (month)

Mean ± SD

29.8 ± 41.0

Baseline BPRS score

Mean ± SD

48.8 ± 14.1

Baseline diseases (n (%))

yes

30 (7.7)

Baseline medicine (n (%))

yes

205 (52.3)

  1. BPRS = Brief Psychiatric Rating Scale